CAH Stock Tickeron detected bullish Stock Pattern: Head-and-Shoulders Bottom CAH on October 31, 2024, netting in a 5.08% gain over 3 weeks

GET DAILY SIGNALS

Get AI intraday signals

CAH - Cardinal Health

Ticker: CAH

Company: Cardinal Health

Gain: +5.08%

Confirmed: 10/31/24

Succeeded: 11/07/24

Total length: 27 days

CAH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for CAH turned positive on November 05, 2024. Looking at past instances where CAH's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 05, 2024. You may want to consider a long position or call options on CAH as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CAH moved above its 50-day moving average on November 01, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CAH crossed bullishly above the 50-day moving average on November 06, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CAH advanced for three days, in of 346 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CAH moved out of overbought territory on November 14, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 54 cases where CAH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CAH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CAH broke above its upper Bollinger Band on November 07, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CAH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.077) is normal, around the industry mean (7.608). P/E Ratio (44.468) is within average values for comparable stocks, (28.511). CAH's Projected Growth (PEG Ratio) (0.329) is slightly lower than the industry average of (4.521). Dividend Yield (0.018) settles around the average of (0.032) among similar stocks. P/S Ratio (0.131) is also within normal values, averaging (35.233).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.